Know Cancer

or
forgot password

Finnish Vitamin D Trial (FIND)


N/A
60 Years
N/A
Not Enrolling
Both
Cardiovascular Diseases, Cancer

Thank you

Trial Information

Finnish Vitamin D Trial (FIND)


Inclusion Criteria:



- Men 60 years or older

- Women 65 years or older

Exclusion Criteria:

- Cardiovascular disease (including myocardial infarction, stroke, transient ischemic
attack, angina pectoris, coronary artery bypass grafting, or percutaneous coronary
intervention).

- Cancer (except non-melanoma skin cancer).

- Any disease or state that raises a vitamin D related safety concern (such as chronic
liver, thyroid or kidney disease, hypercalcemia, sarcoidosis or other granulomatous
diseases such as active chronic tuberculosis or Wegener's granulomatosis).

- Use of supplements yielding vitamin D over 20 µg/day or calcium over 1200 mg/day and
unwillingness to discontinue the use.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Outcome Measure:

Cardiovascular disease

Outcome Description:

CVD incidence in VitD arms vs. placebo arm.

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Tomi-Pekka Tuomainen, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Eastern Finland

Authority:

Finland: Ethics Committee

Study ID:

FIND

NCT ID:

NCT01463813

Start Date:

January 2012

Completion Date:

December 2019

Related Keywords:

  • Cardiovascular Diseases
  • Cancer
  • bone density conservation agents
  • cancer
  • cardiovascular disease
  • cholecalciferol
  • diabetes mellitus, type 2
  • dietary supplements
  • primary prevention
  • vitamin D
  • Cardiovascular Diseases

Name

Location